CVKD

Cadrenal Therapeutics
$2.06
+$0.02 (+0.98%)Jul 27, 2026
0.3PoorMoatMint rating

MoatMint rates Cadrenal Therapeutics (CVKD) 0.3 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 1.4 out of 10.

Key metrics

The numbers that frame CVKD today
Market cap
$5.91M
P/E (TTM)
-0.5
EV / FCF
-0.3
ROIC
1,138.5%
Div yield
0%
Debt / equity
0.0
52wk Low
$1.86
52wk High
$14.64

CVKD stock rating

How CVKD scores on quality, value, growth, momentum and financial health
0.3out of 10
Low overallNeutral business, expensive priceTop 97% of ~5,000 US stocks
QualityPoor1.4/10
GrowthNeutral4.3/10
MomentumPoor0.5/10
ValuePoor0.1/10
Financial HealthPoor1.1/10

Growth

Revenue and earnings trend for CVKD
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about CVKD
Is Cadrenal Therapeutics a good buy?
No. Cadrenal Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks weak. That could put pressure on the long-term business case. We think Cadrenal Therapeutics is selling at a very high price.
What is the market capitalization of CVKD?
Cadrenal Therapeutics's market capitalization is $5.91M.
What is the P/E ratio for CVKD stock?
Cadrenal Therapeutics's current P/E ratio is -0.5.
What is the 52-week high for CVKD stock?
The 52-week high for Cadrenal Therapeutics is $14.64. The current close of $2.06 is 85.9% below that high.
What is the 52-week low for CVKD stock?
The 52-week low for Cadrenal Therapeutics is $1.86. The current close of $2.06 is 10.8% above that low.
Does CVKD stock pay dividends?
Cadrenal Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CVKD?
Cadrenal Therapeutics's Debt / Equity ratio is 0.